Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
British Journal of Haematology|June 29, 2011
Biweekly rituximab, cyclophosphamide, vincristine, non-pegylated liposome-encapsulated doxorubicin and prednisone (R-COMP-14) in elderly patients with poor-risk diffuse large B-cell lymphoma and moderate to high 'life threat' impact cardiopathyGaetano Corazzelli, Ferdinando Frigeri, Manuela Arcamone, et al.
British Journal of Haematology|November 22, 2012
Efficacy and safety of bendamustine for the treatment of patients with recurring Hodgkin lymphomaGaetano Corazzelli, Francesco Angrilli, Alfonso D'Arco, et al.
British Journal of Haematology|November 22, 2011
RD-CODOX-M/IVAC with rituximab and intrathecal liposomal cytarabine in adult Burkitt lymphoma and 'unclassifiable' highly aggressive B-cell lymphomaGaetano Corazzelli, Ferdinando Frigeri, Filippo Russo, et al.
British Journal of Haematology|March 29, 2014
A phase II study of dose-dense and dose-intense ABVD (ABVDDD-DI ) without consolidation radiotherapy in patients with advanced Hodgkin lymphomaFilippo Russo, Gaetano Corazzelli, Ferdinando Frigeri, et al.
British Journal of Haematology|August 2, 2024
Long-term efficacy and safety of dose-dense and dose-intense ABVD without consolidation radiotherapy in patients with advanced Hodgkin lymphoma: A 15-year follow-up of the ABVD<sub>DD-DI</sub> phase II studyGaetano Corazzelli, Annarosa Cuccaro, Emanuela Morelli, et al.
Lancet (London, England)|September 22, 2009
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trialAndrés J M Ferreri, Michele Reni, Marco Foppoli, et al.
Pageof 2